Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Retsas

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of the Royal Society of Medicine|May 1, 1993
Paraneoplastic eosinophilia in malignant melanomaS A Rule, P Waterhouse, C Costello, et al.
Anticancer Research|January 1, 1993
Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell linesC Tolis, A Photiou, R S Camplejohn, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell linesA Photiou, M N Sheikh, D Bafaloukos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patientsS Retsas, K Henry, M Q Mohammed, et al.
Anticancer Research|July 1, 1995
Activity of platinum drugs against melanoma cell lines: is it modulated in vitro in the presence of tamoxifen?M Q Mohammed, A Photiou, P Shah, et al.
Melanoma Research|April 4, 2002
Overexpression of HER-2 in thick melanomaP Eliopoulos, M Q Mohammed, K Henry, et al.
Cancer|April 15, 1994
Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survivalS Retsas, M Quigley, D Pectasides, et al.
Melanoma Research|May 10, 2000
Melanoma and additional primary cancersS Retsas, A Mohith, J Bell, et al.
Planta Medica|February 24, 2001
In vitro cytotoxicity of norviburtinal and isopinnatal from Kigelia pinnata against cancer cell linesS J Jackson, P J Houghton, S Retsas, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Effect of the position of the cyano-group of cyanopregnenolones on their drug metabolic inducing activityP N Kourounakis, E Rekka, V J Demopoulos, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of the Royal Society of Medicine|May 1, 1993
Paraneoplastic eosinophilia in malignant melanomaS A Rule, P Waterhouse, C Costello, et al.
Anticancer Research|January 1, 1993
Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell linesC Tolis, A Photiou, R S Camplejohn, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell linesA Photiou, M N Sheikh, D Bafaloukos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patientsS Retsas, K Henry, M Q Mohammed, et al.
Anticancer Research|July 1, 1995
Activity of platinum drugs against melanoma cell lines: is it modulated in vitro in the presence of tamoxifen?M Q Mohammed, A Photiou, P Shah, et al.
Melanoma Research|April 4, 2002
Overexpression of HER-2 in thick melanomaP Eliopoulos, M Q Mohammed, K Henry, et al.
Cancer|April 15, 1994
Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survivalS Retsas, M Quigley, D Pectasides, et al.
Melanoma Research|May 10, 2000
Melanoma and additional primary cancersS Retsas, A Mohith, J Bell, et al.
Planta Medica|February 24, 2001
In vitro cytotoxicity of norviburtinal and isopinnatal from Kigelia pinnata against cancer cell linesS J Jackson, P J Houghton, S Retsas, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Effect of the position of the cyano-group of cyanopregnenolones on their drug metabolic inducing activityP N Kourounakis, E Rekka, V J Demopoulos, et al.
Pageof 7